title: Disclosure of HIV serostatus to male partner and use of modern contraceptives among women receiving HIV care services in Kampala, Uganda.
abstract: OBJECTIVE
  To investigate whether disclosure of HIV status is associated with use of modern contraceptives (MCs) among women attending HIV care services at an AIDS Information Center (AIC) in an urban setting in Uganda.
  
  
  METHODS
  In a cross-sectional study between March and April 2010, HIV-positive married women aged 15-49years who had received their HIV-positive serostatus results at least 4weeks previously were interviewed at the AIC, Kampala, Uganda. Female use of MCs was compared by HIV disclosure to male marital partners. Log-binomial regression models were used to obtain crude and adjusted prevalence risk ratios (PRRs) and corresponding 95% confidence intervals (CIs).
  
  
  RESULTS
  Nearly three-quarters (72.6%) of the women had disclosed their HIV-positive status to their partner. Overall, use of MCs was reported by 41.0% of the participants. Use of only 1 MC method was similar between those disclosing (81.1%) and those not disclosing (84.3%), but use of dual methods tended to be higher among disclosers (14.4%) than among non-disclosers (10.8%). In adjusted analyses, MC use was 41.0% lower among disclosers than among non-disclosers (adjusted PRR, 0.59; 95% CI, 0.46-0.77).
  
  
  CONCLUSIONS
  HIV serostatus disclosure was associated with lower use of MCs among HIV-positive women in Kampala, Uganda.
authors.affiliation: Department of Epidemiology and Biostatistics, College of Health Sciences, School of Public Health, Makerere University, Kampala, Uganda. Electronic address: zalvivian@yahoo.com.
authors.forename: Vivian W
authors.initials: VW
authors.lastname: Zalwango
authors.forename: Raymond
authors.initials: R
authors.lastname: Tweheyo
authors.forename: Fredrick
authors.initials: F
authors.lastname: Makumbi
mesh_terms: D000293:Adolescent; D000328:Adult; D003267:Contraception / Q000706:statistics & numerical data*; D003268:Contraception Behavior / Q000706:statistics & numerical data; D003270:Contraceptive Agents / Q000008:administration & dosage; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000628:therapy; D006679:HIV Seropositivity / Q000453:epidemiology*; D006801:Humans; D008297:Male; D017533:Marital Status; D008875:Middle Aged; D012044:Regression Analysis; D012747:Sexual Partners; D011795:Surveys and Questionnaires; D014342:Truth Disclosure; D014454:Uganda / Q000453:epidemiology; D055815:Young Adult
chemical_list: D003270:Contraceptive Agents
keywords: HIV serostatus disclosure; Highly active antiretroviral therapy; Modern contraceptive use